Representative David Taylor of Ohio has disclosed a purchase of AT&T stock valued between $3,003 and $45,000. The transaction was dated October 9, 2026, and was reported on October 15, 2026.
According to the filing, Representative Taylor acquired shares of AT&T (NYSE: T). As of the time of the report, AT&T shares were trading at $23.64, representing a gain of 0.5962%.
The report also provides a summary of Representative Taylor's recent trading activity over the last three years. During this period, the representative completed 235 stock transactions totaling more than $361,000. Notable transactions in that timeframe include the sale of shares in UnitedHealth Group and Eli Lilly, as well as the sale of shares in Microsoft and Procter & Gamble.
The disclosure notes that Representative Taylor also purchased shares in Fifth Third Bancorp, RPM International, and Amgen on October 9, 2026, and Amgen on September 22, 2026.
The article emphasizes that congressional transactions are subject to the STOCK Act of 2012, which prohibits members of Congress from using non-public information for personal gain. The text states that while these transactions are not intended to be the primary reason for an investment decision, they may serve as a factor for investors to consider.
